S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bank of America Co. stock logo
BAC
Bank of America
$35.77
+1.5%
$35.61
$24.96
$38.35
$282.25B1.3941.59 million shs43.62 million shs
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$48.30
+1.0%
$51.25
$47.58
$70.93
$96.96B0.3915.78 million shs10.91 million shs
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$603,307.50
+0.5%
$615,876.70
$482,500.00
$647,039.00
$868.76B0.8912,381 shs12,190 shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$181.14
+0.6%
$188.61
$131.81
$200.94
$520.25B1.159.42 million shs9.55 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$125.18
-0.2%
$126.17
$99.14
$133.10
$317.08B0.388.32 million shs5.98 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.39
-0.2%
$27.14
$25.23
$40.56
$143.74B0.6142.48 million shs35.72 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$58.74
+2.7%
$55.63
$36.40
$59.13
$207.96B1.1918.77 million shs24.46 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bank of America Co. stock logo
BAC
Bank of America
+1.58%-1.60%-0.79%+11.02%+19.00%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
+0.98%-1.67%-6.76%-3.61%-30.86%
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
+0.50%-2.17%-2.95%+8.45%+21.89%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
+0.66%-7.22%-6.56%+6.36%+28.27%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-0.14%-0.75%+2.44%+5.30%+9.68%
Pfizer Inc. stock logo
PFE
Pfizer
-0.08%-3.61%-8.06%-10.27%-36.92%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
+2.73%+3.69%+3.03%+22.07%+39.06%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bank of America Co. stock logo
BAC
Bank of America
4.3713 of 5 stars
2.23.02.53.33.11.72.5
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.913 of 5 stars
3.15.03.34.02.61.72.5
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
0.1634 of 5 stars
1.00.00.02.11.70.01.3
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.1157 of 5 stars
2.33.02.52.12.92.51.9
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.7399 of 5 stars
2.35.03.34.13.92.51.3
Pfizer Inc. stock logo
PFE
Pfizer
4.991 of 5 stars
3.25.04.24.82.51.73.1
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
4.5305 of 5 stars
2.25.02.52.53.01.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bank of America Co. stock logo
BAC
Bank of America
2.44
Hold$38.297.05% Upside
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.11
Hold$61.1826.66% Upside
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
2.00
Hold$621,591.003.03% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.65
Moderate Buy$192.056.02% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.58
Moderate Buy$131.254.85% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.35
Hold$36.8845.26% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.42
Hold$58.850.19% Upside

Current Analyst Ratings

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Bank of America Co. stock logo
BAC
Bank of America
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$36.00 ➝ $37.00
4/18/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$51.00 ➝ $52.00
4/18/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$135.00
4/17/2024
Bank of America Co. stock logo
BAC
Bank of America
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$46.00 ➝ $45.00
4/16/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$226.00 ➝ $219.00
4/15/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$221.00 ➝ $216.00
4/15/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$220.00 ➝ $215.00
4/15/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$196.00 ➝ $195.00
4/15/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$219.00 ➝ $217.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/15/2024
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$63.00 ➝ $64.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bank of America Co. stock logo
BAC
Bank of America
$171.91B1.64$4.04 per share8.86$33.60 per share1.06
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$45.01B2.18$12.48 per share3.87$14.49 per share3.33
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$364.48B2.38$34,812.90 per share17.33$393,011.22 per share1.54
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$239.43B2.17$20.47 per share8.85$106.80 per share1.70
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$60.12B5.27$3.05 per share41.11$14.85 per share8.43
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.46$2.94 per share8.63$15.81 per share1.61
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$115.34B1.80$7.65 per share7.68$46.34 per share1.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bank of America Co. stock logo
BAC
Bank of America
$26.52B$2.8912.3810.551.5813.94%10.88%0.89%7/16/2024 (Estimated)
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$8.03B$3.8612.516.951.4917.83%50.95%16.67%4/25/2024 (Confirmed)
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
$96.22B$66,371.289.09N/A26.40%6.91%3.62%5/3/2024 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$49.55B$16.5610.9411.312.2720.05%17.79%1.34%7/12/2024 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$365M$0.14894.1412.731.620.61%9.33%3.61%4/25/2024 (Confirmed)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.519.161.163.62%10.88%4.91%5/1/2024 (Confirmed)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$19.14B$4.7912.2610.741.1015.63%12.30%1.05%7/12/2024 (Estimated)

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/25/2024N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-$4.4730N/A+$4.4730N/AN/AN/A  
4/25/2024N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.12N/A-$2.12N/AN/AN/A  
4/16/2024Q1 24
Bank of America Co. stock logo
BAC
Bank of America
$0.77$0.83+$0.06$0.90$25.49 billion$25.82 billion    
4/12/2024Q1 2024
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.10$1.20+$0.10$1.32$20.19 billion$20.86 billion    
2/24/2024Q4 2023
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/A$5,878.53+$5,878.53-$14,285.94N/A$93.38 billion
2/2/202412/31/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.55$1.70+$0.15$2.53$11.19 billion$11.48 billion    
2/1/2024Q4 2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$0.09$0.03+$0.12$0.54$14.49 billion$14.63 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bank of America Co. stock logo
BAC
Bank of America
$0.962.68%+8.51%33.22%3 Years
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.404.97%+8.20%62.18%N/A
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/AN/AN/AN/AN/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.602.54%+4.00%27.78%2 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.082.46%+6.08%2,200.00%13 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.62%+2.57%466.67%15 Years
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.402.38%+2.14%29.23%3 Years

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/1/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.604.72%4/4/20244/5/20245/1/2024
3/19/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.152.37%4/4/20244/5/20244/30/2024
1/23/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.772.6%3/14/20243/15/20244/5/2024
1/31/2024
Bank of America Co. stock logo
BAC
Bank of America
quarterly$0.242.82%2/29/20243/1/20243/29/2024
1/23/2024
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.352.85%2/1/20242/2/20243/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bank of America Co. stock logo
BAC
Bank of America
1.12
0.79
0.80
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
1.24
1.43
1.31
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
N/A
0.30
0.30
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.29
0.92
0.91
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.89
1.25
1.00
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.14
0.87
0.86

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bank of America Co. stock logo
BAC
Bank of America
213,0007.89 billion7.87 billionOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,1002.03 billion2.02 billionOptionable
Berkshire Hathaway Inc. stock logo
BRK.A
Berkshire Hathaway
360,0001.44 million1.44 millionNot Optionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
309,9262.87 billion2.85 billionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
72,0002.53 billion2.53 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
226,0003.54 billion3.54 billionOptionable

WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Headlines

SourceHeadline
Wells Fargo wants to dismiss former CEO Tim Sloans $34 million lawsuitWells Fargo wants to dismiss former CEO Tim Sloan's $34 million lawsuit
bizjournals.com - April 18 at 8:13 PM
Edward Jones Loses $2.3 Million Arbitration Against Wells FargoEdward Jones Loses $2.3 Million Arbitration Against Wells Fargo
finance.yahoo.com - April 18 at 8:13 PM
Xponance Inc. Buys 30,874 Shares of Wells Fargo & Company (NYSE:WFC)Xponance Inc. Buys 30,874 Shares of Wells Fargo & Company (NYSE:WFC)
marketbeat.com - April 18 at 4:41 PM
Wells Fargo wants to dismiss former CEO Tim Sloans $34M lawsuitWells Fargo wants to dismiss former CEO Tim Sloan's $34M lawsuit
bizjournals.com - April 18 at 3:12 PM
Wells Fargo Innovation Incubator Unveils 2024 Strategic Award WinnersWells Fargo Innovation Incubator Unveils 2024 Strategic Award Winners
finance.yahoo.com - April 18 at 3:12 PM
The 3 Best Bank Stocks to Buy on Q1 Earnings ResultsThe 3 Best Bank Stocks to Buy on Q1 Earnings Results
investorplace.com - April 18 at 2:14 PM
Wells Fargo & Company (NYSE:WFC) Sets New 12-Month High at $58.75Wells Fargo & Company (NYSE:WFC) Sets New 12-Month High at $58.75
marketbeat.com - April 18 at 1:56 PM
Brokers Issue Forecasts for Wells Fargo & Companys Q2 2024 Earnings (NYSE:WFC)Brokers Issue Forecasts for Wells Fargo & Company's Q2 2024 Earnings (NYSE:WFC)
americanbankingnews.com - April 18 at 1:46 AM
High Yields Lure Buyers to US Treasuries, Including 20-Year SaleHigh Yields Lure Buyers to US Treasuries, Including 20-Year Sale
finance.yahoo.com - April 17 at 5:36 PM
Equities Analysts Set Expectations for Wells Fargo & Companys Q2 2024 Earnings (NYSE:WFC)Equities Analysts Set Expectations for Wells Fargo & Company's Q2 2024 Earnings (NYSE:WFC)
marketbeat.com - April 17 at 5:23 PM
ASML’s Earnings Could Bring The Stock to New Highs (WFC)ASML’s Earnings Could Bring The Stock to New Highs (WFC)
marketbeat.com - April 17 at 2:18 PM
Hikari Power Ltd Decreases Stock Position in Wells Fargo & Company (NYSE:WFC)Hikari Power Ltd Decreases Stock Position in Wells Fargo & Company (NYSE:WFC)
marketbeat.com - April 17 at 1:47 PM
Best Momentum Stocks to Buy for April 17thBest Momentum Stocks to Buy for April 17th
zacks.com - April 17 at 11:00 AM
Bank ETFs in Focus on Mixed Q1 EarningsBank ETFs in Focus on Mixed Q1 Earnings
zacks.com - April 17 at 9:00 AM
Wells Fargo Sells Maple Bond for First Time in Two YearsWells Fargo Sells Maple Bond for First Time in Two Years
bloomberg.com - April 17 at 7:34 AM
Wells Fargo & Company Forecasted to Post Q4 2024 Earnings of $1.40 Per Share (NYSE:WFC)Wells Fargo & Company Forecasted to Post Q4 2024 Earnings of $1.40 Per Share (NYSE:WFC)
americanbankingnews.com - April 17 at 2:28 AM
Wells Fargo & Company (NYSE:WFC) Q1 2024 Earnings Call TranscriptWells Fargo & Company (NYSE:WFC) Q1 2024 Earnings Call Transcript
msn.com - April 16 at 4:31 PM
Big banks led by Citi continue layoffs amid pressure to cut costsBig banks led by Citi continue layoffs amid pressure to cut costs
reuters.com - April 16 at 12:47 PM
5 Hot ETFs of a Tumultuous Week5 Hot ETFs of a Tumultuous Week
zacks.com - April 16 at 11:01 AM
Is Wells Fargo Stock Going to $66? 1 Wall Street Analyst Thinks SoIs Wells Fargo Stock Going to $66? 1 Wall Street Analyst Thinks So
fool.com - April 16 at 10:20 AM
Mackenzie Financial Corp Grows Position in Wells Fargo & Company (NYSE:WFC)Mackenzie Financial Corp Grows Position in Wells Fargo & Company (NYSE:WFC)
marketbeat.com - April 16 at 9:35 AM
Brokers Set Expectations for Wells Fargo & Companys Q4 2024 Earnings (NYSE:WFC)Brokers Set Expectations for Wells Fargo & Company's Q4 2024 Earnings (NYSE:WFC)
marketbeat.com - April 16 at 7:43 AM
TradeSun Announces an Agreement With Wells FargoTradeSun Announces an Agreement With Wells Fargo
businesswire.com - April 16 at 6:00 AM
Wells Fargo & Company (NYSE:WFC) Price Target Raised to $66.00 at ArgusWells Fargo & Company (NYSE:WFC) Price Target Raised to $66.00 at Argus
americanbankingnews.com - April 16 at 5:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bank of America logo

Bank of America

NYSE:BAC
Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, non-interest and interest-bearing checking accounts, and investment accounts and products; credit and debit cards; residential mortgages, and home equity loans; and direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, short-term investing options, and merchant services; working capital management solutions; debt and equity underwriting and distribution, and merger-related and other advisory services; and fixed-income and equity research, and certain market-based services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.
Bristol-Myers Squibb logo

Bristol-Myers Squibb

NYSE:BMY
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Berkshire Hathaway logo

Berkshire Hathaway

NYSE:BRK.A
Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. It provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. The company also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydro, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; and flooring, insulation, roofing and engineered, building and engineered components, paints and coatings, and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services; and recreational vehicles, apparel products, jewelry, and custom picture framing products, and alkaline batteries. Further, it manufactures castings, forgings, fasteners/fastener systems, and aerostructures; and seamless pipes, fittings, downhole casing and tubing, and various mill forms. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle apparel and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.
JPMorgan Chase & Co. logo

JPMorgan Chase & Co.

NYSE:JPM
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt market capital-raising services, as well as loan origination and syndication; payments; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations, as well as investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products to high net worth clients. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Wells Fargo & Company logo

Wells Fargo & Company

NYSE:WFC
Wells Fargo & Company, a financial services company, provides diversified banking, investment, mortgage, and consumer and commercial finance products and services in the United States and internationally. The company operates through four segments: Consumer Banking and Lending; Commercial Banking; Corporate and Investment Banking; and Wealth and Investment Management. The Consumer Banking and Lending segment offers diversified financial products and services for consumers and small businesses. Its financial products and services include checking and savings accounts, and credit and debit cards, as well as home, auto, personal, and small business lending services. The Commercial Banking segment provides financial solutions to private, family owned, and certain public companies. Its products and services include banking and credit products across various industry sectors and municipalities, secured lending and lease products, and treasury management services. The Corporate and Investment Banking segment offers a suite of capital markets, banking, and financial products and services, such as corporate banking, investment banking, treasury management, commercial real estate lending and servicing, equity, and fixed income solutions, as well as sales, trading, and research capabilities services to corporate, commercial real estate, government, and institutional clients. The Wealth and Investment Management segment provides personalized wealth management, brokerage, financial planning, lending, private banking, and trust and fiduciary products and services to affluent, high-net worth, and ultra-high-net worth clients. It also operates through financial advisors in brokerage and wealth offices, consumer bank branches, independent offices, and digitally through WellsTrade and Intuitive Investor. The company was founded in 1852 and is headquartered in San Francisco, California.